Second UK study to test gout drug as potential Covid-19 treatment
The anti-inflammatory drug is already being tested in another UK study dubbed RECOVERY, which is the world's largest clinical trial of treatments for patients hospitalised with Covid-19
A large British study looking into potential early-stage Covid-19 treatments will begin testing gout medication colchicine and has widened enrolment criteria for the arm of the trial, University of Oxford researchers said on Wednesday.
The anti-inflammatory drug is already being tested in another UK study dubbed RECOVERY, which is the world's largest clinical trial of treatments for patients hospitalised with Covid-19.